Search Results
(±)13(14)-EpDPA 25 µg | ≥95%
Cayman Chemical
(±)13(14)-EpDPA 1 mg | Purity Not Available
TargetMol
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)13(14)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 13,14-double bond of DHA. It has been detected in rat brain and spinal cord and is a preferred substrate for soluble epoxide hydrolase with a Km value of 3.2 μM. (±)13(14)-EpDPA […]
More Information Supplier Page(±)13(14)-EpDPA| ChemScene 25μg | >98%
ChemScene
(±)13(14)-EpDPA (13,14-EpDPE) is the product of the reaction of cytochrome P-450 epoxygenase with Docosahexaenoic Acid (DHA).(±)13(14)-EpDPA has antihyperalgesic and vasorelaxative activities.
More Information Supplier Page(±)14-HDHA 1 mg | Purity Not Available
TargetMol
(±)14-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. DHA is metabolized to 14(S)-HDHA by human platelets along with 11(S)-HDHA. 14(S)-HDoHE is also produced by salmon gills upon stimulation with calcium ionophore. 14(S)-HDHA was shown to be an […]
More Information Supplier Page(±)14-HDHA 250 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)14-HDHA 100 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)14-HDHA 50 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)14-HDHA 25 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page

